Dr Reddy's Laboratories Ltd
(BOM:500124)
₹
5954.8
-39.15 (-0.65%)
Market Cap: 991.71 Bil
Enterprise Value: 930.26 Bil
PE Ratio: 17.82
PB Ratio: 3.53
GF Score: 97/100 - Q4 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptMay 07, 2024₹6259.15 (-0.66%)Earnings
- Q3 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJan 30, 2024₹5845.75 (+0.03%)Earnings
- Half Year 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptOct 27, 2023₹5385.55 (-0.72%)Earnings
- Q1 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJul 26, 2023₹5476.5 (+0.93%)Earnings
- Q4 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptMay 10, 2023₹4868 (-1.27%)Earnings
- Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call TranscriptMar 16, 2023
- Q3 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJan 25, 2023₹4204.55 (-1.11%)Earnings
- Q2 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptOct 28, 2022₹4460.9 (-0.64%)Earnings
- Q1 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJul 28, 2022₹4259.2 (-0.61%)Earnings
- Dr Reddy's Laboratories Ltd Investor Day TranscriptJun 21, 2022
- Q4 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptMay 19, 2022₹3928.05 (+0.51%)Earnings
- Q3 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJan 28, 2022₹4217.95 (-0.90%)Earnings
- Q2 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptOct 29, 2021₹4670.05 (+2.12%)Earnings
- Q1 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJul 27, 2021₹4844.35 (-10.44%)Earnings
- Q4 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptMay 14, 2021₹5195.85 (-2.00%)Earnings
- Q3 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJan 29, 2021₹4598.65 (-5.69%)Earnings
- Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q2 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptOct 28, 2020₹4949.8 (-2.95%)Earnings
- Q1 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJul 29, 2020₹4300.2 (+6.17%)Earnings
- Q4 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptMay 20, 2020₹3910.75 (+5.71%)Earnings
- Q3 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJan 27, 2020₹3188.95 (+5.31%)Earnings
- Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q2 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptNov 01, 2019₹2754.55 (-1.02%)Earnings
- Q1 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJul 29, 2019₹2652.55 (-1.92%)Earnings
- Q4 2019 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptMay 17, 2019₹2748.1 (-2.01%)Earnings
Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021 / 04:00PM GMT
Release Date Price:
₹5291.1
(-1.23%)
Neha Manpuria
JPMorgan Chase & Co, Research Division - Analyst
Hello, and welcome to the JPMorgan Healthcare Conference. I am Neha Manpuria, the India Health Care Analyst at JPMorgan. It's my pleasure to introduce Mr. Erez Israeli, the CEO of Dr. Reddy's. We will be having a fireside chat in this session and try to address questions on growth strategies of Reddy's. Thank you so much for joining us for this session, sir. It is a pleasure to host you. If you don't mind me directly moving into Q&A, I can start.
Questions & Answers
Erez Israeli;s Laboratories Limited;CEO;Member of the Management Council
Dr. Reddy
'-&
Sure. Thank you for having me.
Neha Manpuria
JPMorgan Chase & Co, Research Division - Analyst
So the first question that I have is Dr. Reddy's today probably has a very well-balanced business with a growing emerging market presence, improving position in India post the Wockhardt acquisition and a strong U.S. pipeline. From here on,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)